Evidence map›Paper›PMID 38090148›Full record

ArticleFrontiers in genetics2023

Personalized medicine in a community health system: the NorthShore experience.

Sean P David, Henry M Dunnenberger, Sarah Choi, Allison DePersia, Nadim Ilbawi, Christopher Ward, Dyson T Wake, Janardan D Khandekar, Yvette Shannon, Kristen Hughes and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Risk for coronary artery disease among individuals with normal low-density lipoprotein cholesterol (LDL-C) levels.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Development and validation of a genetic probability for venous thromboembolism.Research and practice in thrombosis and haemostasis · 2025
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Sean P DavidDepartment of Family Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Henry M DunnenbergerMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Sarah ChoiMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Allison DePersiaMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Nadim IlbawiDepartment of Family Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Christopher WardMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Dyson T WakeMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Janardan D KhandekarDepartment of Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Yvette ShannonMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Kristen HughesMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Nicholas MillerMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Kathy A MangoldDepartment of Pathology, University of Chicago Pritzker School of Medicine, Chicago, IL, United States.
Linda M SabatiniDepartment of Pathology, University of Chicago Pritzker School of Medicine, Chicago, IL, United States.
Donald L HelsethMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Jianfeng XuMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
Alan SandersCenter for Psychiatric Genetics, Department of Psychiatry and Behavioral Sciences, NorthShore University HealthSystem, Evanston, IL, United States.
Karen L KaulOutcomes Research Network, NorthShore University HealthSystem, Evanston, IL, United States.
Peter J HulickMark R. Neaman Center for Personalized Medicine, NorthShore University HealthSystem, Evanston, IL, United States.
NorthShore University HealthSystem · USUniversity of Chicago · USResearch Network (United States) · US

Funding

The Institute for Translational MedicineUL1TR002389 · NCATS · UNIVERSITY OF CHICAGO · PI Joshua J Jacobs, DAVID O MELTZER · 2017 to 2026
$71.6M
NCATS NIH HHS UL1 TR002389
6 · The paper itself

Abstract

Genomic and personalized medicine implementation efforts have largely centered on specialty care in tertiary health systems. There are few examples of fully integrated care systems that span the healthcare continuum. In 2014, NorthShore University HealthSystem launched the Center for Personalized Medicine to catalyze the delivery of personalized medicine. Successful implementation required the development of a scalable family history collection tool, the Genetic and Wellness Assessment (GWA) and Breast Health Assessment (BHA) tools; integrated pharmacogenomics programming; educational programming; electronic medical record integration; and robust clinical decision support tools. To date, more than 225,000 patients have been screened for increased hereditary conditions, such as cancer risk, through these tools in primary care. More than 35,000 patients completed clinical genetic testing following GWA or BHA completion. An innovative program trained more than 100 primary care providers in genomic medicine, activated with clinical decision support and access to patient genetic counseling services and digital healthcare tools. The development of a novel bioinformatics platform (FLYPE) enabled the incorporation of genomics data into electronic medical records. To date, over 4,000 patients have been identified to have a pathogenic or likely pathogenic variant in a gene with medical management implications. Over 33,000 patients have clinical pharmacogenomics data incorporated into the electronic health record supported by clinical decision support tools. This manuscript describes the evolution, strategy, and successful multispecialty partnerships aligned with health system leadership that enabled the implementation of a comprehensive personalized medicine program with measurable patient outcomes through a genomics-enabled learning health system model that utilizes implementation science frameworks.

Indexed as

genetic counselinggenetic testingpersonalized medicinepharmacogenomicsprecision healthprecision medicineprimary care

Identifiers

PMID38090148
PMCPMC10713750
OpenAlexW4389097631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.